Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23321647 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: Losartan and  Atenolol or  Propranolol;   Drug: Atenolol or Propranolol

Indicates status has not been verified in more than two years